The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRentokil Initial Regulatory News (RTO)

Share Price Information for Rentokil Initial (RTO)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 407.70
Bid: 406.40
Ask: 406.60
Change: 6.70 (1.67%)
Spread: 0.20 (0.049%)
Open: 408.90
High: 409.60
Low: 404.30
Prev. Close: 401.00
RTO Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Notice of Capital Markets Day

28 Sep 2021 07:00

RNS Number : 1305N
Rentokil Initial PLC
28 September 2021
 

28 September 2021

 

RENTOKIL INITIAL PLC (RTO)

 

Notice of Capital Markets Day - 'Hygiene: The New Pest Control',

revised growth targets and changes to Category and Regional structure

 

 

Rentokil Initial plc will be holding a Capital Markets Day for investors and analysts at 12.00pm today at The Great Hall, Chartered Accountants' Hall, One Moorgate Place, London EC2R 6EA.

 

The event will include a series of presentations by senior executive and operational management to provide greater insight into the Group's Hygiene business. These sessions will include presentations on our core washroom business, growth opportunities outside of the washroom (including Air Care, Dental Hygiene, Medical, Specialist Hygiene, Wellbeing, Plants and Scenting) expansion of our geographic footprint, M&A and our financial model to compound growth. The event will start with a number of sessions on our Pest Control business, focusing on digital technology, PestConnect, innovation and M&A. Attendees will also be able to view displays on innovation, digital capability and ESG during the event.

 

The Company will not give an update on current trading today, but will be announcing revised medium-term growth targets as well as changes to its Category and Regional structure from 1 January 2022. No changes are being made to the Company's capital allocation model or dividend policy.

 

Medium-term growth targets

 

The Company will announce the following changes to its medium-term targets:

 

Previous Targets

New Targets

 

Organic Revenue growth:

 

Group: 3% - 4%

Pest Control: 4% - 6%

Hygiene: 2% - 3%

Workwear: N/A

 

 

Organic Revenue growth:

 

Group: 4% - 5% (ex. Disinfection)

Pest Control: 4.5% - 6.5%

Hygiene & Wellbeing: 4% - 6% (ex. Disinfection)

Workwear: 3% - 4%

 

Ongoing Revenue growth: 5% to 8%

 

Ongoing Revenue growth: 6% to 9%

(of which M&A 2% to 5%)

Ongoing Operating Profit growth: c.10%

Ongoing Operating Profit growth: 10%+

Free Cash Flow: c.90% cash conversion

Free Cash Flow: c.90% cash conversion

 

Category structure

 

In response to the COVID-19 pandemic and the increasing importance of hygiene and wellbeing services, we are expanding our Hygiene category with effect from 1 January 2022. The enlarged category, called Hygiene & Wellbeing, will comprise our current Hygiene operations together with our Ambius, Dental Hygiene and Cleanroom services operations, previously part of our Protect & Enhance category. In addition, the Group's UK Property Care business (also formerly in Protect & Enhance) will join the Pest Control category. France Workwear will become the Group's third business category.

 

Regional structure

 

The number of regions within the Group will remain unchanged. The Rest of World businesses, which were previously included within the UK & Rest of World region, will be transferred to other regions to better reflect their geographic locations. This includes: Poland and the Nordics, which will be transferred to Europe; our Caribbean operations, which will move to Latin America; and our businesses in MENAT, which will move to the Asia region and which will be renamed Asia & MENAT. Our Sub-Saharan Africa operations will continue to be reported within the UK. There will be no major changes to our North America region, with the exception of Puerto Rico transferring to Latin America. The Pacific region will remain unchanged, comprising Australia, New Zealand and Fiji. Consequently, the five regions will be named North America, Europe, UK & Sub-Saharan Africa, Asia & MENAT and Pacific. This new reporting structure will take effect from 1 January 2022.

 

Rentokil Initial will publish its Q3 Trading Statement at 7.00am on 21 October 2021.

Today's presentations will be web cast live and will be available on a replay facility for the foreseeable future at www.rentokil-initial.com. If you would like to follow our live webcast, online registration is required and will be available from 7.00am this morning on https://rentokilinitial.connectid.cloud with log in for the event from 11:30am. For access links and information please visit rentokil-initial.com.

 

Rentokil Initial is one of the largest business services companies in the world, operating in 87 countries. The Company offers route-based services including Pest Control, Hygiene and Wellbeing, and Workwear through over 45,000 employees around the world. For more information, visit www.rentokil-initial.com.

 

Enquiries:

 

Investors / Analysts:

Katharine Rycroft

Rentokil Initial plc

07811 270734

Media:

Malcolm Padley

Rentokil Initial plc

07788 978199

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCEAKNXASAFEFA
Date   Source Headline
14th Oct 20224:37 pmRNSHolding(s) in Company
14th Oct 20229:30 amRNSAdditional Listing
13th Oct 20225:42 pmRNSHolding(s) in Company
13th Oct 20223:05 pmRNSHolding(s) in Company
12th Oct 20221:53 pmRNSAcquisition of Terminix Completion
10th Oct 20221:57 pmRNSHolding(s) in Company
10th Oct 20221:52 pmRNSHolding(s) in Company
10th Oct 20221:38 pmRNSHolding(s) in Company
7th Oct 20226:10 pmRNSRentokil Initial
6th Oct 20222:23 pmRNSResult of General Meeting
3rd Oct 20222:36 pmRNSBlock listing Interim Review
30th Sep 202211:42 amRNSDirector Declaration
14th Sep 20225:55 pmRNSDirector/PDMR Shareholding
14th Sep 202212:21 pmRNSDirector/PDMR Shareholding
7th Sep 20222:38 pmRNSPublication of Circular-Prospectus & GM Notice
22nd Aug 20227:00 amRNSHolding(s) in Company
5th Aug 20222:02 pmRNSDirector/PDMR Shareholding
28th Jul 20227:00 amRNS2022 Interim Results
27th Jul 20229:54 amRNSDirector Declaration
18th Jul 20223:11 pmRNSHolding(s) in Company
15th Jul 20225:30 pmRNSHolding(s) in Company
15th Jul 202211:57 amRNSHolding(s) in Company
27th Jun 20222:27 pmRNSPost stabilisation notice - Rentokil Initial Plc
22nd Jun 20224:16 pmRNSHolding(s) in Company
21st Jun 20223:37 pmRNSDirector/PDMR Shareholding
20th Jun 20229:12 amRNSPre stabilisation notice - Rentokil Initial Plc
20th May 202210:20 amRNSDirector/PDMR Shareholding
12th May 20227:00 amRNSResult of AGM
21st Apr 20227:00 amRNSQ1 Trading Update
1st Apr 20227:00 amRNSBlock listing Interim Review
31st Mar 20226:15 pmRNSTotal Voting Rights
30th Mar 20229:44 amRNSAnnual Financial Report
29th Mar 20222:20 pmRNSDirector/PDMR Shareholding
25th Mar 20224:31 pmRNSDirector/PDMR Shareholding
15th Mar 20227:00 amRNSUpdate on Terminix acquisition
14th Mar 202211:00 amRNSAdditional Listing
3rd Mar 20227:00 amRNSFinal Results
2nd Mar 202210:29 amRNSDirector/PDMR Shareholding
28th Feb 20224:47 pmRNSHolding(s) in Company
22nd Dec 20215:38 pmRNSDirector/PDMR Shareholding
21st Dec 20214:09 pmRNSDirector/PDMR Shareholding
16th Dec 20217:00 amRNSFurther re Terminix Acqn S&P reaffirms BBB rating
15th Dec 20212:02 pmRNSDirector/PDMR Shareholding
14th Dec 20217:00 amRNSAcquisition of Terminix by Rentokil Initial plc
22nd Oct 202110:42 amRNSDirector Declaration
21st Oct 20217:00 amRNSQ3 Trading Update
1st Oct 202110:00 amRNSBlock listing Interim Review
28th Sep 20217:00 amRNSNotice of Capital Markets Day
17th Aug 20216:09 pmRNSDirector/PDMR Shareholding
12th Aug 20214:48 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.